This systematic review aimed to examine the effects of long-term oxygen therapy on the mental state of patients with chronic obstructive pulmonary disease.
Methods
Web of Science, Medline, CINAHL, EMBASE, ProQuest, and Cochrane Library were selected to search for relevant studies. We followed the Cochrane Handbook for Systematic Reviews of Interventions, adopted the Cochrane risk-of-bias tool and Risk Of Bias In Non-randomized Studies of Interventions tool, and synthesized the outcomes narratively with Grading of Recommendations, Assessment, Development and Evaluations evidence profile.
Results
Six studies were included. Moderate quality of evidence supported no effects of long-term oxygen therapy on the mental state in patients with severe resting hypoxemia and moderate resting hypoxemia (or exertional desaturation) at follow-up of 6 to 12 months; however, adverse effects on mental state among patients with moderate resting or exertional desaturation were reported at the follow-up of 36 to 48 months.
Discussion
Nurses should focus on the mental state of patients treated with long-term oxygen therapy, especially those who use it for a prolonged time. Due to ethical constraints in this study, a quasi-experimental study with faithful consideration of internal validity can be commenced in the future.
Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Available from: https://goldcopd.org/2023-gold-report-2/.
2.
KentBDMitchellPDMcNicholasWT. Hypoxemia in patients with COPD: cause, effects, and disease progression. Int J Chron Obstruct Pulmon Dis2011; 6: 199–208.
3.
KhorYHGutmanLAbu HusseinN, et al.Incidence and prognostic significance of hypoxemia in fibrotic interstitial lung disease: an international cohort study. Chest2021; 160: 994–1005.
4.
WellsJMEsteparRSMcDonaldMN, et al.Clinical, physiologic, and radiographic factors contributing to development of hypoxemia in moderate to severe COPD: a cohort study. BMC Pulm Med2016; 16: 169.
5.
SundhJEkströmM. Risk factors for developing hypoxic respiratory failure in COPD. Int J Chron Obstruct Pulmon Dis2017; 12: 2095–2100.
6.
ZysmanMDesleeGPerezT, et al.Burden and characteristics of severe chronic hypoxemia in a real-world cohort of subjects with COPD. Int J Chron Obstruct Pulmon Dis2021; 16: 1275–1284.
7.
KimDKJacobsonFLWashkoGR, et al.Clinical and radiographic correlates of hypoxemia and oxygen therapy in the COPDGene study. Respir Med2011; 105: 1211–1221.
8.
TashkinDPCelliBSennS, et al.A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med2008; 359: 1543–1554.
9.
MagnetFSSchwarzSBCallegariJ, et al.Long-term oxygen therapy: comparison of the German and British guidelines. Respiration2017; 93: 253–263.
10.
EkströmMAhmadiZBornefalk-HermanssonA, et al.Oxygen for breathlessness in patients with chronic obstructive pulmonary disease who do not qualify for home oxygen therapy. Cochrane Database Syst Rev2016; 11: CD006429.
11.
HardingeMSuntharalingamJWilkinsonT, et al.Guideline update: the British Thoracic Society guidelines on home oxygen use in adults. Thorax2015; 70: 589–591.
12.
Medical Research Council Working Party. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Lancet1981; 1: 681–686.
13.
Nocturnal Oxygen Therapy Trial Group. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Ann Intern Med1980; 93: 391–398.
14.
LacasseYTanAYMMaltaisF, et al.Home oxygen in chronic obstructive pulmonary disease. Am J Respir Crit Care2018; 197: 1254–1264.
WalkerHKHallWDHurstJW (eds). Clinical methods: The history, physical, and laboratory examinations. 3rd ed. Boston: Butterworths, 1990.
17.
LegrainVTortaDM.Cognitive psychology and neuropsychology of nociception and pain. In Pain, emotion and cognition. Springer: Cham, 2015, pp. 3–20.
18.
DuryR. COPD and emotional distress: not always noticed and therefore untreated. Br J Community Nurs2016; 21: 138–141.
19.
SchulerMWittmannMFallerH, et al.The interrelations among aspects of dyspnea and symptoms of depression in COPD patients—a network analysis. J Affect Disord2018; 240: 33–40.
20.
PumarMIGrayCRWalshJR, et al.Anxiety and depression—important psychological comorbidities of COPD. J Thorac Dis2014; 6: 1615–1631.
21.
Fei F, J Siegert R, Zhang X, Gao W, Koffman J. Symptom clusters, associated factors and health-related quality of life in patients with chronic obstructive pulmonary disease: a structural equation modelling analysis. J Clin Nurs2023;32(1-2): 298–310. https://doi.org/10.1111/jocn.16234
22.
AlliboneESoaresTWilsonA. Safe and effective use of supplemental oxygen therapy. Nurs Stand2018; 33: 43–50.
23.
EkströmMRingbaekT. Which patients with moderate hypoxemia benefit from long-term oxygen therapy? Ways forward. Int J Chron Obstruct Pulmon Dis2018; 13: 231–235.
24.
WenXHLiYHanD, et al.The relationship between cognitive function and arterial partial pressure O2 in patients with COPD: a meta-analysis. Medicine (Baltimore)2018; 97: e9599.
25.
KellyCALynesDO’BrienMR, et al.A wolf in sheep’s clothing? Patients’ and healthcare professionals’ perceptions of oxygen therapy: an interpretative phenomenological analysis. Clin Respir J2018; 12: 616–632.
26.
GoldbartJYohannesAMWoolrychR,et al. ‘It is not going to change his life but it has picked him up’: a qualitative study of perspectives on long term oxygen therapy for people with chronic obstructive pulmonary disease. Health Qual Life Outcomes2013; 11: 124.
27.
CullenDLStifflerD. Long-term oxygen therapy: review from the patients’ perspective. Chron Respir Dis2009; 6: 141–147.
28.
BorgstedeMScholzM. Quantitative and qualitative approaches to generalization and replication—a representationalist view. Front Psychol2021; 12: 605191.
29.
RazafshaMBehforuziHAzariH, et al.Qualitative versus quantitative methods in psychiatric research. In: KobeissyFH (eds) Psychiatric disorders: Methods and protocols. New York: Humana New York, 2012.
30.
ZielińskiJ. Effects of long-term oxygen therapy in patients with chronic obstructive pulmonary disease. Curr Opin Pulm Med1999; 5: 81–87.
BollmeierSGHartmannAP. Management of chronic obstructive pulmonary disease: a review focusing on exacerbations. Am J Health Syst Pharm2020; 77: 259–268.
33.
DonaldsonGCLawMKowlessarB, et al.Impact of prolonged exacerbation recovery in chronic obstructive pulmonary disease. Am J Respir Crit Care Med2015; 192: 943–950.
34.
VanderWeeleTJ. Principles of confounder selection. Eur J Epidemiol2019; 34: 211–219.
LevineBEBigelowDBHamstraRD, et al.The role of long-term continuous oxygen administration in patients with chronic airway obstruction with hypoxemia. Ann Intern Med1967; 66: 639–650.
37.
SterneJACSavovićJPageMJ, et al.Rob 2: a revised tool for assessing risk of bias in randomised trials. Br Med J2019; 366: l4898.
38.
SterneJACHernánMAReevesBC, et al.ROBINS-I: a tool for assessing risk of bias in non-randomized studies of interventions. Br Med J2016; 355: i4919.
HeatonRKGrantIMcSweenyAJ, et al.Psychologic effects of continuous and nocturnal oxygen therapy in hypoxemic chronic obstructive pulmonary disease. Arch Intern Med1983; 143: 1941–1947.
42.
Long-Term Oxygen Treatment Trial Research Group, AlbertRKAuDH, et al.A randomized trial of long-term oxygen for COPD with moderate desaturation. N Engl J Med2016; 375: 1617–1627.
43.
DengXQMoHFQingXG, et al.The psychological effects of long term domicilinary oxygen therapy on stable chronic obstructive pulmonary disease with hypoxaemia. Chin J Behav Med Sci2001; 10: 173–174. in Chinese.
44.
EatonTLewisCYoungP, et al.Long-term oxygen therapy improves health-related quality of life. Respir Med2004; 98: 285–293.
45.
MesquitaCBKnautCCaramLMO, et al.Impact of adherence to long-term oxygen therapy on patients with COPD and exertional hypoxemia followed for one year. J Bras Pneumol2018; 44: 390–397.
46.
OkubadejoAAPaulEAJonesPW, et al.Does long-term oxygen therapy affect quality of life in patients with chronic obstructive pulmonary disease and severe hypoxaemia?Eur Respir J1996; 9: 2335–2339.
47.
MoustgaardHClaytonGLJonesHE, et al.Impact of blinding on estimated treatment effects in randomised clinical trials: meta-epidemiological study. Br Med J2020; 368: l6802.
48.
McNairDMLorrMDropplemanLF. EDITS manual for the profile of mood states. San Diego: Educational and Industrial Testing Service, 1971.
49.
GüellRCasanPSangenísM, et al.Quality of life in patients with chronic respiratory disease: the Spanish version of the Chronic Respiratory Questionnaire (CRQ). Eur Respir J1998; 11: 55–60.
JonesPWQuirkFHBaveystockCM. The St George's Respiratory Questionnaire. Respir Med1991; 85: 25–31.
52.
ZigmondASSnaithRP. The hospital anxiety and depression scale. Acta Psychiatr Scand1983; 67: 361–370.
53.
JinXJWangJY. Interpretation of the literature on how to use ROBINS-I and other non-randomized research bias risk assessment tools to rate the quality of evidence bodies. Chin J Evid Based Pediatr2021; 16: 442–445. In Chinese.
54.
TaylorALaBedzSKimYJ, et al.Home oxygen reassessment and discontinuation after hospital discharge among patients hospitalised for COPD. Chest2020; 158: A1816.
55.
StorgaardLHWeinreichUMLaursenBS. COPD patients’ experience of long-term domestic oxygen-enriched nasal high flow treatment: a qualitative study. COPD2020; 17: 175–183.
56.
BuenoGHCamposCJGTuratoER, et al.Experiences in elderly people with chronic obstructive pulmonary disease in relation to the use of long-term home oxygen therapy: a qualitative study about feelings attributed to therapy. BMC Pulm Med2022; 22: 96.
57.
KarkiAMoranteJCervellioneKL, et al.Oxygen indications and utilization in a diverse, urban community setting. J Cardiopulm Rehabil Prev2020; 40: 438–440.
58.
IheanachoIZhangSKingD, et al.Economic burden of chronic obstructive pulmonary disease (COPD): a systematic literature review. Int J Chron Obstruct Pulmon Dis2020; 15: 439–460.
59.
YohannesAMKaplanAHananiaNA. Anxiety and depression in chronic obstructive pulmonary disease: recognition and management. Cleve Clin J Med2018; 85: S11–S18.
60.
AndrianopoulosVGloecklRVogiatzisI,et al.Cognitive impairment in COPD: should cognitive evaluation be part of respiratory assessment?Breathe (Sheff)2017; 13: e1–e9.
61.
BransonRD. Oxygen therapy in COPD. Respir Care2018; 63: 734–748.
62.
BookerR. Life in the COPD straitjacket: improving lives of sufferers. Br J Nurs2003; 12: 1061.
63.
DudleyDLGlaserEMJorgensonBN, et al.Psychosocial concomitants to rehabilitation in chronic obstructive pulmonary disease. Part I. Psychosocial and psychological considerations. Chest1980; 77: 413–420.
64.
PinnockHKendallMMurraySA, et al.Living and dying with severe chronic obstructive pulmonary disease: multi-perspective longitudinal qualitative study. BMJ Support Palliat Care2011; 1: 174–183.
65.
HabrakenJMPolsJBindelsPJ, et al.The silence of patients with end-stage COPD: a qualitative study. Br J Gen Pract2008; 58: 844–849.
66.
MeekPM. Patients with acute exacerbations of COPD saw anxiety as a sign, rather than cause, of breathlessness. Evid Based Nurs2005; 8: 61.
67.
PhanTCarterOAdamsC, et al.Discriminant validity of the Hospital Anxiety and Depression Scale, Beck Depression Inventory (II) and Beck Anxiety Inventory to confirmed clinical diagnosis of depression and anxiety in patients with chronic obstructive pulmonary disease. Chron Respir Dis2016; 13: 220–228.
68.
RazaHANokesBWesseliusL, et al.Long-term oxygen therapy in patients with chronic obstructive pulmonary disease and moderate hypoxemia. J Am Osteopath Assoc2018; 118: 663–665.
69.
AgustíAVogelmeierCFanerR. COPD 2020: changes and challenges. Am J Physiol Lung Cell Mol Physiol2020; 319: L879–L883.
70.
HardavellaGKarampinisIFrilleA, et al.Oxygen devices and delivery systems. Breathe (Sheff)2019; 15: e108–e116.
